Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02923934
Brief Title: A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

First Submitted : October 2, 2016
First Submitted that Met QC Criteria : October 4, 2016
First Posted : October 5, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 30, 2019
Last Update Posted : February 1, 2019